5-HYDROXYTRYPTAMINE RECEPTOR 1A

Approval Year

Substance Class	Protein Created by `admin` on `Sun Dec 18 08:03:23 UTC 2022` Edited by `admin` on `Sun Dec 18 08:03:23 UTC 2022`
Protein Type	RECEPTOR
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	UKK18ES9TF
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

5-HYDROXYTRYPTAMINE RECEPTOR 1A

Common Name

English

ADRB2RL1

Common Name

English

5-HT1A

Common Name

English

ADRBRL1

Common Name

English

G-21

Common Name

English

SEROTONIN RECEPTOR 1A

Common Name

English

Code System Code Type Description

UNIPROT

P08908

Created by admin on Sun Dec 18 08:03:27 UTC 2022 , Edited by admin on Sun Dec 18 08:03:27 UTC 2022

PRIMARY

PHAROS

P08908

Created by admin on Sun Dec 18 08:03:27 UTC 2022 , Edited by admin on Sun Dec 18 08:03:27 UTC 2022

PRIMARY

FDA UNII

UKK18ES9TF

Created by admin on Sun Dec 18 08:03:27 UTC 2022 , Edited by admin on Sun Dec 18 08:03:27 UTC 2022

PRIMARY

From	To
1_109	1_187

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_10
N	1_11
N	1_24

Related Record Type Details


					RAT9OHA1YH

BEFIRADOL

AGONIST -> TARGET


					8BA8T27317

MEPHEDRONE

INHIBITOR -> TARGET


					F6RJL8B278

CARIPRAZINE

PARTIAL AGONIST->TARGET

Qualification:

Amount:


					L6UH7ZF8HC

RISPERIDONE

WEAK INHIBITOR->TARGET

Interaction Type:

INHIBITOR

Qualification:

Amount:


					2G7CCY4TFN

CUMI-101 C-11

RADIOLIGAND->TARGET

Qualification:

Amount:


					V3H1ZVV9S6

NORQUETIAPINE

PARTIAL AGONIST->TARGET

Qualification:

Amount:


					Y9FMC4513X

PIRENPERONE

INHIBITOR -> TARGET


					8NA5SWF92O

LYSERGIDE

AGONIST -> TARGET

Amount:


					BJ4HF6IU1D

PINDOLOL

PARTIAL AGONIST->TARGET


					9JQ994EAB3

U-92016A

AGONIST -> TARGET

Amount:


					54EJ303F0R

ACEPROMAZINE

INHIBITOR -> TARGET


					A9M89XG7QW

2-BROMOMESCALINE

AGONIST -> TARGET

Amount:


					FY875H1BG6

BMS-181101

AGONIST -> TARGET


					RHO99102VC

MESCALINE

AGONIST -> TARGET

Amount:


					6417Y85XND

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, (+)-

AGONIST -> TARGET


					WUB601BHAA

DIMETHYLTRYPTAMINE

AGONIST -> TARGET

Interaction Type:

AGONIST

Qualification:

Amount:


					2FS66TH3YW

ZOLMITRIPTAN

AGONIST -> TARGET


					U5XOB9AQ15

5-MEO-AMT

AGONIST -> TARGET

Amount:


					3CW8YYD822

BEFIRADOL F-18

RADIOLIGAND->TARGET


					19GBJ60SN5

CANNABIDIOL

ACTIVATOR -> TARGET


					71IH826FEG

WAY-100635

INHIBITOR -> TARGET

Comments:

Exhibited antagonism activity at both presynaptic and postsynaptic 5-HT1A receptor sites.

Qualification:

Amount:


					N4Y2V13I7F

CUMI-101

PARTIAL AGONIST->TARGET

Qualification:

Amount:


					3E926T8YGD

4-FLUORO-5-METHOXY-DMT

AGONIST -> TARGET

Amount:


					0N1X9UW73U

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, (-)-

AGONIST -> TARGET


					26HUS7139V

OCAPERIDONE

AGONIST -> TARGET


					BB4A3YJ2N9

CPC-222

LIGAND->TARGET

Amount:


					2J3YBM1K8C

BREXPIPRAZOLE

PARTIAL AGONIST->TARGET


					C1LJO185Q9

OXITRIPTAN

AGONIST -> TARGET


					H276H25KW0

SSR-181507

AGONIST -> TARGET


					U42B7VYA4P

CHLORPROMAZINE

INHIBITOR -> TARGET


					12D06G8W8E

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE

AGONIST -> TARGET

Comments:

The strongest receptor binding affinity for 5-MeO-DiPT is at the 5-HT1A receptor.

Amount:


					2GT50C8U60

SUNEPITRON

AGONIST -> TARGET

Interaction Type:

SELECTIVE


					S239O2OOV3

VILAZODONE

PARTIAL AGONIST->TARGET


					Y6JQX3L6LP

1B-LSD

PARTIAL AGONIST->TARGET

Qualification:

Amount:


					3K6270MG59

Ulotaront

AGONIST -> TARGET

Amount:


					K2GV9632S9

E-2110 FREE BASE

INHIBITOR -> TARGET

Amount:


					22QOO9B8KI

ELETRIPTAN

AGONIST -> TARGET

Comments:

Eletriptan binds with high affinity to 5-HT1B, 5-HT1D and 5-HT1F receptors, has modest affinity for 5-HT1A, 5-HT1E, 5-HT2B and 5-HT7 receptors

Interaction Type:

BINDING


					TK65WKS8HL

BUSPIRONE

PARTIAL AGONIST->TARGET


					NJK9JT8ZSA

CPC-222 C-11

RADIOLIGAND->TARGET

Amount:


					6RN01B78NY

4-HYDROXY-N-METHYL-N-ETHYLTRYPTAMINE

AGONIST -> TARGET

Amount:


					8R78F6L9VO

SUMATRIPTAN

AGONIST -> TARGET


					3O2K1S3WQV

VORTIOXETINE

AGONIST -> TARGET


					3YQY8P5QGX

WAY-100635 C-11

RADIOLIGAND->TARGET

Qualification:

Amount:


					U9SA2HB256

(11C)(R)-(-)-RWAY

RADIOLIGAND->TARGET

Amount:


					X8L60BA01I

BRILAROXAZINE

PARTIAL AGONIST->TARGET


					838F01T721

PALIPERIDONE

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

Amount:


					FYC6YY5RYL

CP-94253

AGONIST -> TARGET

Amount:


					DV8DX4568D

CORYDALMINE, (-)-

AGONIST -> TARGET

Amount:


					LD88X72QPZ

MPPF F-18

RADIOLIGAND->TARGET

Qualification:

Amount:


					DAV805YGOX

WAY-100635 CARBONYL-C-11

RADIOLIGAND->TARGET

Qualification:

Amount:


					VBH9V79F9V

FCWAY F-18

RADIOLIGAND->TARGET

Amount:


					J4CZH8D9EN

6-FLUORO-DMT

AGONIST -> TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL